Tuesday
SESSION 8: MORE ABOUT TBADs, CONTROVERSIES ABOUT TIMING, INDICATIONS AND VALUE OF TEVAR TREATMENT FOR PATIENTS WITH UNCOMPLICATED TBADs
Location: Grand Ballroom East, 3rd Floor
Moderators:Matt M. Thompson, MD / Mark A. Adelman, MD  
SESSION 8 SCHEDULE
4:38 PM - 4:43 PM Best Definition For Acute, Subacute And Chronic TBADs: Why Is TEVAR Treatment In The Subacute Phase (From 8-30 Days After Symptom Onset) Best And Safest
  Presenter(s):Guangqi Chang, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
4:44 PM - 4:49 PM DEBATE: The Case For Treating All Acute Uncomplicated TBAD Patients With TEVAR: Optimal Timing For The Procedure
  Presenter(s):William D. Jordan Jr., MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
4:50 PM - 4:55 PM DEBATE: Why Most Acute Uncomplicated TBAD Patients Should Not Be Treated By TEVAR: Which Ones Should Be And When
  Presenter(s):Michel Makaroun, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
4:56 PM - 5:01 PM New Information From The IRAD Registry: Optimal Timing Of TEVAR For TBAD; Predictors Of Remodeling Complications And Need For Additional Procedures After TEVAR: Best Treatment For Visceral Ischemia
  Presenter(s):Santi Trimarchi, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
5:02 PM - 5:07 PM Uncomplicated TBAD Is A Misnomer: Most TBAD Patients Will Benefit From TEVAR: Importance Of Aortic Remodeling: Optimal Timing Of TEVAR
  Presenter(s):Christoph A. Nienaber, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
5:08 PM - 5:13 PM DEBATE: With Uncomplicated TBAD Patients TEVAR Should Be Delayed For 2-12 Weeks After Symptom Onset To Decrease Risk Of Retrograde Type A Dissection
  Presenter(s):Matt M. Thompson, MD / Peter J.E. Holt, MD, PhD / Ian Loftus, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
5:14 PM - 5:19 PM DEBATE: Not So: TEVAR Treatment Of Uncomplicated TBADs In First 10 Days After Symptom Onset Is Best And Safe Under Certain Conditions And With Certain Precautions
  Presenter(s):Edward Y. Woo, MD / Tareq M. Massimi, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
5:20 PM - 5:25 PM Do We Need Another Randomized Controlled Trial (RCT) Comparing TEVAR And Good Medical Treatment Alone With Good Medical Treatment For Uncomplicated TBADs
  Presenter(s):Richard P. Cambria, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
5:26 PM - 5:31 PM Need For, Status Of And Required Elements For A RCT Comparing Good Medical Management With And Without Early TEVAR For The Treatment Of Uncomplicated TBADs
  Presenter(s):Firas F. Mussa, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
5:32 PM - 5:37 PM Risks Of TEVAR For Asymptomatic Uncomplicated TBAD Patients And How Does TEVAR Change Cardiac Function: How Does Advanced Aortic Imaging Help Decision Making
  Presenter(s):Rachel E. Clough, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
5:38 PM - 5:43 PM Favorable Impact Of Early TEVAR On 5-Year Survival Of Patients With Uncomplicated TBADs: From A Statewide (CA) Registry: But We Still Need A RCT
  Presenter(s):Virendra I. Patel, MD, MPH / Mark Conrad, MD, MMSc / Richard P. Cambria, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
5:44 PM - 5:52 PM Panel Discussion
END OF SESSION 8
previous next